Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

215
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
215
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75
Seizures: Classification01:13

Seizures: Classification

426
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
426
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial.

American journal of respiratory and critical care medicine·2026
Same author

Relationships between pre-, post-, and inter-ictal psychiatric symptoms in patients with epilepsy.

PCN reports : psychiatry and clinical neurosciences·2026
Same author

PERSIST-PWI trial: Rationale and design of a multicenter randomized controlled trial comparing pulmonary vein isolation alone with pulmonary vein isolation plus posterior wall isolation using pulsed field ablation in patients with persistent atrial fibrillation.

Heart rhythm O2·2026
Same author

Nationwide Implementation of Non-Mandatory Preventive Medicine Programmes in Japanese Municipalities: A Descriptive Cross-Sectional Survey and Evidence-Practice Gap Analysis.

Research square·2026
Same author

Reply to: "Amino acid strategy in early postoperative parenteral nutrition".

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

Risk Factors for Delirium in Hospitalized Patients With Medical Conditions Receiving Dual Orexin Receptor Antagonists: A Retrospective Cohort Study.

Journal of clinical psychopharmacology·2026

Related Experiment Video

Updated: Jul 23, 2025

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.4K

A knowledge-based simple education program for patients with epilepsy in Japan: Effects sustained after the program

Takenori Morita1, Hiromichi Motooka2, Yuji Ito3

  • 1Department of Neuropsychiatry, Kurume University, Japan; Sasebo-Aikei Hospital, Japan.

Epilepsy & Behavior : E&B
|July 14, 2023
PubMed
Summary
This summary is machine-generated.

An educational program significantly improved epilepsy knowledge and attitudes in patients with epilepsy (PWE). However, individuals with depression require tailored interventions for sustained benefits.

Keywords:
AttitudeDepressionKnowledge-basedPerceptionPsychoeducation

More Related Videos

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI
11:00

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI

Published on: March 19, 2021

4.5K
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

11.2K

Related Experiment Videos

Last Updated: Jul 23, 2025

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.4K
Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI
11:00

Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI

Published on: March 19, 2021

4.5K
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

11.2K

Area of Science:

  • Neurology
  • Psychiatry
  • Medical Education

Background:

  • Epilepsy management requires comprehensive patient education to improve understanding and attitudes.
  • Educational interventions can positively impact patients with epilepsy (PWE), but the influence of comorbid depression needs further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of a novel educational program on epilepsy knowledge, attitudes, depression, and quality of life in patients with epilepsy (PWE).

Main Methods:

  • Thirty-five PWE participated in a lecture-based education program using a specialized textbook.
  • Standardized scales including the Knowledge about Epilepsy Scale (KES), Attitude toward Epilepsy Scale (AES), Quality of Life in Epilepsy Inventory (QOLIE-31-P), and Beck Depression Inventory (BDI) were administered.
  • Patient scores were compared to those of medical students and residents.

Main Results:

  • Post-education, PWE showed significant improvements in KES and AES scores, surpassing those of medical students and residents.
  • These improvements in knowledge and attitude were sustained for at least six months.
  • While all participants showed improved KES scores, only non-depressed individuals demonstrated significant improvements in AES, highlighting a disparity in response based on depression status.

Conclusions:

  • Enhanced epilepsy knowledge positively influences attitudes and perceptions among PWE.
  • Specialized educational strategies are crucial for addressing the unique needs of PWE experiencing depression to optimize outcomes.